The lower kidney uptake of 177Lu-PSMA-617 in the study conducted by Benesova et al. [33] can be explained by the tumour sink effect, where higher tumour load (higher PSMA expression of PC-3 PIP tumours) lead to lower kidney dose [42]. This evidence concerns the gene FOLH1 and neoplasm.